William F. Huffman

2.8k total citations
67 papers, 1.4k citations indexed

About

William F. Huffman is a scholar working on Social Psychology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, William F. Huffman has authored 67 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Social Psychology, 25 papers in Molecular Biology and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in William F. Huffman's work include Neuroendocrine regulation and behavior (26 papers), Electrolyte and hormonal disorders (20 papers) and Chemical Synthesis and Analysis (13 papers). William F. Huffman is often cited by papers focused on Neuroendocrine regulation and behavior (26 papers), Electrolyte and hormonal disorders (20 papers) and Chemical Synthesis and Analysis (13 papers). William F. Huffman collaborates with scholars based in United States, United Kingdom and Netherlands. William F. Huffman's co-authors include Lewis B. Kinter, F L Stassen, James M. Samanen, William H. Miller, James F. Callahan, Kenneth A. Newlander, Cheryl A. Janson, Walter E. DeWolf, Xiayang Qiu and David Payne and has published in prestigious journals such as Journal of the American Chemical Society, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

William F. Huffman

65 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William F. Huffman United States	21	717	569	186	185	176	67	1.4k
Herbert G. Bull United States	24	1.1k 1.5×	316 0.6×	38 0.2×	97 0.5×	86 0.5×	37	2.0k
William J. Hoekstra United States	27	609 0.8×	728 1.3×	24 0.1×	701 3.8×	82 0.5×	70	2.2k
Shrenik K. Shah United States	20	501 0.7×	676 1.2×	5 0.0×	506 2.7×	48 0.3×	41	2.0k
Hideya Hayashi Japan	23	820 1.1×	427 0.8×	5 0.0×	210 1.1×	30 0.2×	70	1.8k
Tattanahalli L. Nagabhushan United States	21	711 1.0×	166 0.3×	10 0.1×	71 0.4×	40 0.2×	42	2.3k
R. T. BORCHARDT United States	24	1.0k 1.4×	183 0.3×	7 0.0×	200 1.1×	35 0.2×	49	1.7k
Gilbert Arthur Canada	24	1.1k 1.5×	272 0.5×	13 0.1×	30 0.2×	16 0.1×	102	1.7k
Dipti Gupta United States	21	810 1.1×	314 0.6×	25 0.1×	17 0.1×	84 0.5×	73	1.4k
Justin S. Bryans United Kingdom	20	577 0.8×	504 0.9×	8 0.0×	105 0.6×	25 0.1×	45	1.6k
Pradip K. Bhatnagar United States	20	715 1.0×	153 0.3×	6 0.0×	100 0.5×	35 0.2×	54	1.5k

Countries citing papers authored by William F. Huffman

Since Specialization

Citations

This map shows the geographic impact of William F. Huffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William F. Huffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William F. Huffman more than expected).

Fields of papers citing papers by William F. Huffman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William F. Huffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William F. Huffman. The network helps show where William F. Huffman may publish in the future.

Co-authorship network of co-authors of William F. Huffman

This figure shows the co-authorship network connecting the top 25 collaborators of William F. Huffman. A scholar is included among the top collaborators of William F. Huffman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William F. Huffman. William F. Huffman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Seefeld, Mark A., William H. Miller, Kenneth A. Newlander, et al.. (2001). Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents. Bioorganic & Medicinal Chemistry Letters. 11(17). 2241–2244. 52 indexed citations

Heerding, Dirk A., George Chan, Walter E. DeWolf, et al.. (2001). 1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI). Bioorganic & Medicinal Chemistry Letters. 11(16). 2061–2065. 110 indexed citations

Lark, Michael W., George B. Stroup, Shing Mei Hwang, et al.. (1999). Design and Characterization of Orally Active Arg-Gly-Asp Peptidomimetic Vitronectin Receptor Antagonist SB 265123 for Prevention of Bone Loss in Osteoporosis. Journal of Pharmacology and Experimental Therapeutics. 291(2). 612–617. 37 indexed citations

Hoog, Susan S., Baoguang Zhao, Evon Winborne, et al.. (1995). A Check on Rational Drug Design: Crystal Structure of a Complex of Human Immunodeficiency Virus Type 1 Protease with a Novel .gamma.-Turn Mimetic Inhibitor. Journal of Medicinal Chemistry. 38(17). 3246–3252. 30 indexed citations

Kinter, Lewis B., S Caltabiano, & William F. Huffman. (1993). Anomalous antidiuretic activity of antidiuretic hormone antagonists. Biochemical Pharmacology. 45(9). 1731–1737. 16 indexed citations

NEWLANDER, K. A., James F. Callahan, M. Lane Moore, Thaddeus A. Tomaszek, & William F. Huffman. (1993). A novel constrained reduced-amide inhibitor of HIV-1 protease derived from the sequential incorporation of .gamma.-turn mimetics into a model substrate. Journal of Medicinal Chemistry. 36(16). 2321–2331. 35 indexed citations

Callahan, James F., Ellen E. Codd, Carole Lemieux, et al.. (1989). Cyclic enkephalin analog containing .alpha.-amino-.beta.-mercapto-.beta.,.beta.-pentamethylenepropionic acid at position 2 or 5. Journal of Medicinal Chemistry. 32(2). 302–304. 6 indexed citations

Brooks, David P., Paul F. Koster, Christine R. Albrightson, et al.. (1989). Vasopressin receptor antagonism in rhesus monkey and man: stereochemical requirements. European Journal of Pharmacology. 160(1). 159–162. 7 indexed citations

Brooks, David P., Paul F. Koster, C R Albrightson-Winslow, et al.. (1988). SK&F 105494 is a potent antidiuretic hormone antagonist in the rhesus monkey (Macaca mulatta).. PubMed. 245(1). 211–5. 16 indexed citations

10.

Brickson, B, Lewis B. Kinter, David P. Brooks, et al.. (1988). SK&F 105494: a potent antidiuretic hormone antagonist devoid of partial agonist activity in dogs.. PubMed. 247(3). 897–901. 7 indexed citations

11.

Brooks, David P., Paul F. Koster, F L Stassen, et al.. (1988). Flushing and haemodynamic responses to vasopressin peptides in the rhesus monkey. British Journal of Pharmacology. 94(3). 759–764. 7 indexed citations

12.

Hempel, Judith C., William F. Huffman, Garland R. Marshall, et al.. (1988). Design, synthesis, and biological activity of a peptide mimic of vasopressin. Journal of Medicinal Chemistry. 31(4). 742–744. 2 indexed citations

13.

Ali, Fadia E., William F. Huffman, Lewis B. Kinter, et al.. (1987). Potent vasopressin antagonist modified at the carboxy-terminal tripeptide tail. Journal of Medicinal Chemistry. 30(12). 2291–2294. 2 indexed citations

14.

Kinter, Lewis B., Susanne Churchill, F L Stassen, M. Lane Moore, & William F. Huffman. (1987). Vasopressin antagonism in the squirrel monkey (Saimiri sciureus).. Journal of Pharmacology and Experimental Therapeutics. 241(3). 797–803. 10 indexed citations

15.

Moore, M. Lane, et al.. (1986). Vasopressin antagonist analogs modified at position 7. International journal of peptide & protein research. 28(4). 379–385. 2 indexed citations

16.

DeMarinis, Robert M., Gregory Gallagher, Ralph F. Hall, et al.. (1986). ChemInform Abstract: Syntheses and in vitro Evaluation of 4‐(2‐Aminoethyl)‐2(3H)‐indolones and Related Compounds as Peripheral Prejunctional Dopamine Receptor Agonists.. Chemischer Informationsdienst. 17(43). 1 indexed citations

17.

Huffman, William F., et al.. (1983). 4-(Aminoalkyl)-7-hydroxy-2(3H)-indolones, a novel class of potent presynaptic dopamine receptor agonists. Journal of Medicinal Chemistry. 26(7). 933–935. 20 indexed citations

18.

Johnson, William S., et al.. (1979). Biomimetic polyene cyclizations. Synthesis of racemic 19‐norprogesterone. Recueil des Travaux Chimiques des Pays-Bas. 98(3). 125–126. 4 indexed citations

19.

Huffman, William F., Ralph F. Hall, Jennifer Grant, & Kenneth G. Holden. (1978). ChemInform Abstract: NUCLEAR ANALOGUES OF β‐LACTAM ANTIBIOTICS. PART 4. TOTAL SYNTHESIS OF BISNORISOPENICILLINS FROM ANTIBACTERIALLY ACTIVE MONOCYCLIC β‐LACTAM PRECURSORS. Chemischer Informationsdienst. 9(46). 1 indexed citations

20.

Little, J. Maxwell, et al.. (1961). THE EFFECT OF 5-HYDROXYTRYPTAMINE (SEROTONIN) ON RENAL HEMODYNAMICS, WATER AND ELECTROLYTE EXCRETION. Journal of Pharmacology and Experimental Therapeutics. 131(1). 44–48. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact